To the fullest extent of the law, no responsibility is assumed by Kidney Disease: Improving Global Outcomes (KDIGO), the International Society of Nephrology, or Elsevier for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Of cial Journal of the International Society of Nephrology Elsevier KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease S1 KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group OPEN www.kidney-international.org contents VOL 99 | ISSUE 3S | MARCH 2021 KDIGO 2021 CLINICAL PRACTICE GUIDELINE FOR THE MANAGEMENT OF BLOOD PRESSURE IN CHRONIC KIDNEY DISEASE KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease S3 Tables, gures, and supplementary material S7 KDIGO Executive Committee S8 Reference keys S9 CKD nomenclature S10 Conversion factors and Glossary of terms for blood pressure management S11 Abbreviations and acronyms S14 Updates to the KDIGO guideline format S18 Work Group membership S23 Summary of recommendation statements and practice points S26 Chapter 1: Blood pressure measurement S32 Chapter 2: Lifestyle interventions for lowering blood pressure in patients with CKD not receiving dialysis S37 Chapter 3: Blood pressure management in patients with CKD, with or without diabetes, not receiving dialysis S55 Chapter 4: Blood pressure management in kidney transplant recipients (CKD S59 Chapter 5: Blood pressure management in children with CKD S62 Methods for guideline development S71 Biographic and disclosure information The development and publication of this guideline were supported by KDIGO. 